A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures
This study has been completed.
Study NCT00236860
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: October 7, 2005
Last Updated: July 23, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
